Today: 20 March 2026
Browse Category

NSE:ADANIPORTS 13 November 2025 - 2 February 2026

India stock market today: Nifty, Sensex shut for Republic Day; tariffs, Axis Bank results in focus

India stock market today: Nifty, Sensex shut for Republic Day; tariffs, Axis Bank results in focus

Indian stock exchanges closed Monday for Republic Day after the Nifty 50 fell 0.95% Friday to 25,048.65, its sharpest weekly drop in four months. The Sensex ended at 81,537.70. Adani group shares slid after a U.S. regulator sought court approval in a fraud case. Markets reopen Tuesday ahead of the Feb. 1 Union Budget.
India Stock Market Wrap 28–29 November 2025: Sensex, Nifty Hover Near Record Highs as Rupee Hits New Low and GDP Jumps 8.2%

India Stock Market Wrap 28–29 November 2025: Sensex, Nifty Hover Near Record Highs as Rupee Hits New Low and GDP Jumps 8.2%

India’s Sensex closed at 85,706.67 on Friday, down 0.02%, while the Nifty 50 slipped 0.05% to 26,202.95, just below record highs. The rupee hit a record low as foreign investors remained net sellers, despite India posting its strongest quarterly growth in six quarters. Nifty Auto and Pharma led sector gains; IT and Oil & Gas lagged.
Dalal Street in Turmoil: Sensex Plunges 2,500 Points in a Week – Should You Buy the Dip or Brace for More?

Sensex, Nifty Close Flat on Nov 13, 2025; Bank Nifty Hits Record High, Asian Paints Jumps; Rupee Near 88.66 as CPI Prints Record Low

The Sensex closed nearly flat at 84,478.67 and the Nifty 50 at 25,879.15 on Thursday as investors paused ahead of Bihar election results. The Nifty Bank index hit a record intraday high near 58,616. Asian Paints surged to a 52-week high after strong earnings, while Mahindra & Mahindra and Adani Ports slipped. October CPI fell to 0.25% y/y, and the rupee ended at 88.6650 per US dollar.

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop